Bezjak Mark's most recent trade in Zimmer Biomet Holdings Inc was a trade of 1,621 Restricted Stock Units done . Disclosure was reported to the exchange on March 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 1,621 | 1,621 | - | - | Restricted Stock Units | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 1,621 | 13,772 (0%) | 0% | 0 | Common Stock | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.86 per share. | 06 Mar 2025 | 638 | 13,134 (0%) | 0% | 104.9 | 66,901 | Common Stock |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 8,829 | 8,829 | - | - | Restricted Stock Units | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 2,519 | 12,845 (0%) | 0% | 0 | Common Stock | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 2,519 | 5,037 | - | - | Restricted Stock Units | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.46 per share. | 20 Feb 2025 | 694 | 12,151 (0%) | 0% | 103.5 | 71,801 | Common Stock |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 7,865 | 0 | - | - | Restricted Stock Units | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 7,865 | 12,280 (0%) | 0% | 0 | Common Stock | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 7,865 | 7,865 | - | - | Restricted Stock Units | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.00 per share. | 14 Feb 2025 | 1,954 | 10,326 (0%) | 0% | 101 | 197,354 | Common Stock |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 1,622 | 3,242 | - | - | Restricted Stock Units | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 1,622 | 4,753 (0%) | 0% | 0 | Common Stock | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.82 per share. | 06 Mar 2024 | 395 | 4,358 (0%) | 0% | 125.8 | 49,699 | Common Stock |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2024 | 1,528 | 3,535 (0%) | 0% | 0 | Common Stock | |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2024 | 1,528 | 0 | - | - | Restricted Stock Units | |
Zimmer Biomet Holdings Inc | Bezjak Mark | President, Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.80 per share. | 25 Feb 2024 | 404 | 3,131 (0%) | 0% | 128.8 | 52,035 | Common Stock |
Zimmer Biomet Holdings Inc | Mark Bezjak | President, Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 7,556 | 7,556 | - | - | Restricted Stock Units |